NO145337C - Analogifremgangsmaate for fremstilling av farmakologisk aktive metylamin-derivater - Google Patents

Analogifremgangsmaate for fremstilling av farmakologisk aktive metylamin-derivater

Info

Publication number
NO145337C
NO145337C NO771941A NO771941A NO145337C NO 145337 C NO145337 C NO 145337C NO 771941 A NO771941 A NO 771941A NO 771941 A NO771941 A NO 771941A NO 145337 C NO145337 C NO 145337C
Authority
NO
Norway
Prior art keywords
preparation
pharmacologically active
analogy procedure
methylamine derivatives
methylamine
Prior art date
Application number
NO771941A
Other languages
English (en)
Norwegian (no)
Other versions
NO145337B (no
NO771941L (no
Inventor
Charles Pigerol
Jean-Claude Vernieres
Pierre Eymard
Madeleine Broll
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO771941L publication Critical patent/NO771941L/no
Publication of NO145337B publication Critical patent/NO145337B/no
Publication of NO145337C publication Critical patent/NO145337C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO771941A 1976-06-03 1977-06-02 Analogifremgangsmaate for fremstilling av farmakologisk aktive metylamin-derivater NO145337C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE842528 1976-06-03

Publications (3)

Publication Number Publication Date
NO771941L NO771941L (no) 1977-12-06
NO145337B NO145337B (no) 1981-11-23
NO145337C true NO145337C (no) 1982-03-03

Family

ID=3861370

Family Applications (1)

Application Number Title Priority Date Filing Date
NO771941A NO145337C (no) 1976-06-03 1977-06-02 Analogifremgangsmaate for fremstilling av farmakologisk aktive metylamin-derivater

Country Status (17)

Country Link
JP (1) JPS6039261B2 (US06589383-20030708-C00041.png)
AR (4) AR213646A1 (US06589383-20030708-C00041.png)
AT (1) AT352088B (US06589383-20030708-C00041.png)
AU (1) AU511705B2 (US06589383-20030708-C00041.png)
DK (1) DK146063C (US06589383-20030708-C00041.png)
ES (2) ES459466A1 (US06589383-20030708-C00041.png)
FI (1) FI63015C (US06589383-20030708-C00041.png)
FR (2) FR2374901A1 (US06589383-20030708-C00041.png)
GR (1) GR61148B (US06589383-20030708-C00041.png)
MX (1) MX4778E (US06589383-20030708-C00041.png)
NL (1) NL7706052A (US06589383-20030708-C00041.png)
NO (1) NO145337C (US06589383-20030708-C00041.png)
NZ (1) NZ184161A (US06589383-20030708-C00041.png)
PT (1) PT66623B (US06589383-20030708-C00041.png)
SE (2) SE452317B (US06589383-20030708-C00041.png)
YU (1) YU129577A (US06589383-20030708-C00041.png)
ZA (1) ZA773151B (US06589383-20030708-C00041.png)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES437790A1 (es) * 1974-05-20 1977-05-16 Labaz Procedimiento para preparar composiciones farmaceuticas y veterinarias.
BE842528R (fr) * 1976-06-03 1976-12-03 Derives actifs de methylamine, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions

Also Published As

Publication number Publication date
PT66623B (en) 1978-11-07
ZA773151B (en) 1978-04-26
DK244677A (da) 1977-12-04
SE452763B (sv) 1987-12-14
YU129577A (en) 1983-01-21
NO145337B (no) 1981-11-23
JPS6039261B2 (ja) 1985-09-05
AR213646A1 (es) 1979-02-28
NZ184161A (en) 1980-10-08
ES459466A1 (es) 1978-08-16
FI771780A (US06589383-20030708-C00041.png) 1977-12-04
AR215052A1 (es) 1979-08-31
GR61148B (en) 1978-09-27
AU2556177A (en) 1978-11-30
SE8206445D0 (sv) 1982-11-12
MX4778E (es) 1982-09-15
FI63015C (fi) 1983-04-11
AT352088B (de) 1979-08-27
JPS52148006A (en) 1977-12-08
AR215053A1 (es) 1979-08-31
ES470379A1 (es) 1979-10-16
AR215175A1 (es) 1979-09-14
SE452317B (sv) 1987-11-23
DK146063B (da) 1983-06-20
NO771941L (no) 1977-12-06
NL7706052A (nl) 1977-12-06
FI63015B (fi) 1982-12-31
PT66623A (en) 1977-07-01
SE7706448L (sv) 1977-12-04
SE8206445L (sv) 1982-11-12
ATA395877A (de) 1979-02-15
DK146063C (da) 1983-11-14
AU511705B2 (en) 1980-09-04
FR2372795A1 (fr) 1978-06-30
FR2374901A1 (fr) 1978-07-21
FR2372795B1 (US06589383-20030708-C00041.png) 1983-08-12
FR2374901B1 (US06589383-20030708-C00041.png) 1981-04-17

Similar Documents

Publication Publication Date Title
NO148813C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater
NO800626L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive polyolderivater
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO153177C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater.
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO141411C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive erytromycin-derivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
SE431544B (sv) Analogiforfarande for framstellning av farmakologiskt aktiva 4-pyrimidon-derivat
NO150884C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater
NO145842C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO821848L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
NO145951C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolinderivater
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO149388C (no) Analogi-fremgangsmaate for fremstilling av farmakologisk aktive karbostyril-derivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO148291C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO148673C (no) Analogifremgangsmaate ved fremstilling av farmakologisk virksomme tiofenderivater
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO780743L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner
NO145950C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive homoftalimider
NO142524C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive cykloheksylfenyl-derivater
SE428688B (sv) Forfarande for framstellning av nya antidiabetiskt aktiva isooxazolderivat